Showing results (371-380 of 514) with videos related to

Sort By:
Pageof 52
Carbohydrate Polymers|May 25, 2023
Fabrication of graded porous structure of hydroxypropyl cellulose hydrogels via temperature-induced phase separationAlexia Tialiou, Zahraa H Athab, Robert T Woodward, et al.
Pharmaceutics|May 27, 2026
Mn(II)-Tagged DOTA-Modified Sugar-Based Biopolymers as Gadolinium-Free Contrast Agents for Magnetic Resonance ImagingIrena Pashkunova-Martic, Joachim Friske, Silvester J Bartsch, et al.
Electrophoresis|June 9, 2007
Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CEAndrei R Timerbaev, Lidia S Foteeva, Alexander V Rudnev, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|January 10, 2012
Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compoundsCaroline Bartel, Anna K Bytzek, Yulia Yu Scaffidi-Domianello, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2016
Self-assembled Pt<sub>2</sub>L<sub>2</sub> boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cellsO Domarco, D Lötsch, J Schreiber, et al.
Frontiers in Chemistry|May 3, 2014
Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexesMuhammad Hanif, Samuel M Meier, Alexey A Nazarov, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|August 2, 2016
Photoreduction of Terrigenous Fe-Humic Substances Leads to Bioavailable Iron in OceansAmir Blazevic, Ewelina Orlowska, Wolfgang Kandioller, et al.
Chemistry & Biodiversity|October 31, 2008
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patientsChristian G Hartinger, Michael A Jakupec, Stefanie Zorbas-Seifried, et al.
Pageof 52